XML 47 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Operating Segments (Tables)
12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Active Partner Companies by Segment
The Company’s active partner companies as of December 31, 2014 by segment were as follows for the years ended December 31, 2014, 2013 and 2012:
 
Healthcare 
 
Safeguard Primary Ownership as of December 31,
 
 
Partner Company
2014
 
2013
 
2012
 
Accounting Method
AdvantEdge Healthcare Solutions, Inc.
40.1%
 
40.1%
 
40.2%
 
Equity
Dabo Health, Inc.
15.3%
 
8.0%
 
NA
 
Cost
Good Start Genetics, Inc.
29.9%
 
30.0%
 
30.0%
 
Equity
InfoBionic, Inc.
27.8%
 
NA
 
NA
 
Equity
Medivo, Inc.
34.5%
 
34.5%
 
30.0%
 
Equity
NovaSom, Inc.
31.7%
 
30.3%
 
30.3%
 
Equity
Propeller Health, Inc.
24.6%
 
NA
 
NA
 
Equity
Putney, Inc.
28.3%
 
27.6%
 
27.6%
 
Equity
Quantia, Inc.
42.3%
 
35.1%
 
NA
 
Equity
Syapse, Inc.
27.0%
 
NA
 
NA
 
Equity
Trice Medical™
31.9%
 
NA
 
NA
 
Equity
 
Technology 
 
Safeguard Primary Ownership as of December 31,
 
 
Partner Company
2014
 
2013
 
2012
 
Accounting Method
AppFirst, Inc.
34.3%
 
34.3%
 
35.0%
 
Equity
Apprenda, Inc.
21.6%
 
22.0%
 
NA
 
Equity
Beyond.com, Inc.
38.2%
 
38.2%
 
38.3%
 
Equity
Bridgevine, Inc.
17.2%
 
22.7%
 
21.7%
 
Cost (1)
Clutch Holdings, Inc.
29.6%
 
24.0%
 
NA
 
Equity
DriveFactor, Inc.
40.6%
 
40.6%
 
35.4%
 
Equity
Hoopla Software, Inc.
25.6%
 
25.3%
 
25.3%
 
Equity
Lumesis, Inc.
45.7%
 
44.2%
 
31.6%
 
Equity
MediaMath, Inc.
20.7%
 
22.5%
 
22.2%
 
Equity
Pneuron Corporation
27.6%
 
27.6%
 
NA
 
Equity
Spongecell, Inc.
23.0%
 
23.0%
 
23.1%
 
Equity
Transactis, Inc.
24.8%
 
NA
 
NA
 
Equity
WebLinc, Inc.
29.2%
 
NA
 
NA
 
Equity
Segment Data from Operations
The following represents segment data from operations:
 
 
For the Year Ended December 31, 2014

Healthcare

Technology

Total
Segments

Other
Items

Total
 
(In thousands)
Operating loss
$

 
$

 
$

 
$
(18,970
)
 
$
(18,970
)
Other income (loss), net
31,820

 

 
31,820

 
(163
)
 
31,657

Interest income

 

 

 
1,901

 
1,901

Equity loss
(3,944
)
 
(10,831
)
 
(14,775
)
 
(560
)
 
(15,335
)
Net income (loss)
27,876

 
(10,831
)
 
17,045

 
(22,194
)
 
(5,149
)
Segment Assets:
 
 
 
 
 
 
 
 
 
December 31, 2014
62,292

 
88,408

 
150,700

 
167,754

 
318,454

 
 
 
 
 
 
 
 
 
 
 
For the Year Ended December 31, 2013
 
Healthcare
 
Technology
 
Total
Segments
 
Other
Items
 
Total
 
(In thousands)
Operating loss
$

 
$

 
$

 
$
(21,644
)
 
$
(21,644
)
Other income (loss), net
(857
)
 

 
(857
)
 
1,240

 
383

Interest income

 

 

 
2,646

 
2,646

Equity income (loss)
(31,706
)
 
20,899

 
(10,807
)
 
(1,800
)
 
(12,607
)
Net income (loss)
(32,563
)
 
20,899

 
(11,664
)
 
(23,861
)
 
(35,525
)
Segment Assets:
 
 
 
 
 
 
 
 
 
December 31, 2013
74,939

 
69,471

 
144,410

 
201,586

 
345,996

 
 
 
 
 
 
 
 
 
 
 
For the Year Ended December 31, 2012
 
Healthcare
 
Technology
 
Total
Segments
 
Other
Items
 
Total
 
(In thousands)
Operating loss
$

 
$

 
$

 
$
(19,473
)
 
$
(19,473
)
Other income (loss), net
19,884

 

 
19,884

 
(10,546
)
 
9,338

Interest income

 

 

 
2,926

 
2,926

Equity income (loss)
(26,544
)
 
(119
)
 
(26,663
)
 
146

 
(26,517
)
Net loss
(6,660
)
 
(119
)
 
(6,779
)
 
(32,583
)
 
(39,362
)
Net Loss from Other Items
Net loss from Other Items was as follows:
 
 
Year Ended December 31,
 
2014
 
2013
 
2012
 
(In thousands)
Corporate operations
$
(22,194
)
 
$
(23,861
)
 
$
(32,583
)
Income tax benefit (expense)

 

 

 
$
(22,194
)
 
$
(23,861
)
 
$
(32,583
)